亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Association of Reperfusion and Procedural Characteristics with Endovascular Thrombectomy Outcomes in Large Core Stroke: Sub‐Analysis from the SELECT2 Trial

冲程(发动机) 医学 芯(光纤) 内科学 血管内治疗 心脏病学 外科 计算机科学 动脉瘤 电信 机械工程 工程类
作者
A. Hassan,Michael Abraham,Spiros Blackburn,Muhammad Shazam Hussain,Mahmoud Dibas,Michael Chen,Yin Hu,Deep Pujara,Nabeel Herial,Jenny P. Tsai,Ronald F. Budzik,Nathan Manning,Osman Kozak,Ricardó A. Hanel,Amin N. Aghaebrahim,Chirag D. Gandhi,Fawaz Al‐Mufti,Andrew Cheung,Bernard Yan,Peter Mitchell
出处
期刊:Annals of Neurology [Wiley]
卷期号:97 (1): 175-184 被引量:2
标识
DOI:10.1002/ana.27104
摘要

Endovascular thrombectomy (EVT) was shown to be safe and efficacious in patients with large core stroke in multiple randomized controlled trials. However, the impact of reperfusion and other procedural metrics on EVT outcomes in this population has not been well‐characterized. Methods From the SELECT2 trial, we evaluated the association between reperfusion status, first‐pass effect (near‐complete or complete reperfusion [extended thrombolysis in cerebral infarction (eTICI) 2c‐3] in 1 pass), procedure time and primary technique (aspiration vs stent‐retriever) with functional outcomes in patients receiving EVT across ASPECTS (3 vs 4 vs 5) and core estimate strata (<70 vs ≥70ml, <100 vs ≥100ml, and <150 vs ≥150ml). Results Of 180 patients who received thrombectomy, 144 (80%) achieved successful reperfusion (eTICI 2b‐3) and demonstrated better clinical outcomes (adjusted generalized odds ratios [aGenOR]: 1.48, 95% confidence interval [CI]: 1.01–2.15), compared with unsuccessful reperfusion. Results were consistent across ASPECTS and core estimate strata. Additionally, complete or near‐complete reperfusion (eTICI 2c‐3) was associated with better functional outcome (aGenOR: 1.99, 95% CI: 1.33–2.97) in patients achieving successful reperfusion. Functional outcome point estimates favored those with first‐pass‐effect (42 of 167 (25%), aGenOR: 1.46, 95% CI: 0.96–2.24). Longer procedure time was associated with worse modified Rankin scale (mRS) distribution (aGenOR: 0.92, 95% CI: 0.87–0.96, p ‐value = 0.001 for 10 minutes increment). Aspiration‐first technique was used in 43 of 154 (25%) patients and was not associated with higher reperfusion (88% vs 78%, p = 0.18) or better functional outcome (aGenOR: 0.74, 95% CI: 0.50–1.10) as compared with stent‐retriever first. Interpretation Successful reperfusion resulted in improved clinical outcomes in large core patients across baseline ischemic core strata. Near complete or complete reperfusion was further associated with better outcomes, whereas prolonged procedures were associated with worse outcomes. Results were consistent regardless of the technique used. ANN NEUROL 2025;97:175–184
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
4秒前
星落枝头发布了新的文献求助10
11秒前
15秒前
qq完成签到 ,获得积分10
18秒前
Alex发布了新的文献求助10
21秒前
孤星独韵发布了新的文献求助10
22秒前
彬彬有礼完成签到 ,获得积分10
23秒前
28秒前
33秒前
iveuplife发布了新的文献求助10
34秒前
40秒前
小蘑菇应助怡然平露采纳,获得10
52秒前
爱科研的小凡完成签到 ,获得积分10
53秒前
55秒前
1分钟前
1分钟前
泥嚎芽发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
清爽的罡应助科研通管家采纳,获得10
1分钟前
深情安青应助科研通管家采纳,获得10
1分钟前
怡然平露发布了新的文献求助10
1分钟前
1分钟前
Akim应助Amekaji采纳,获得10
1分钟前
曹兆发布了新的文献求助100
1分钟前
1分钟前
ajing完成签到,获得积分10
1分钟前
YYL完成签到 ,获得积分10
1分钟前
呵呵哒发布了新的文献求助30
1分钟前
Ava应助iveuplife采纳,获得10
1分钟前
1分钟前
还活着完成签到,获得积分10
1分钟前
iveuplife完成签到,获得积分10
1分钟前
扶摇完成签到 ,获得积分10
1分钟前
zhuzhu026完成签到,获得积分10
1分钟前
英姑应助moment采纳,获得10
1分钟前
昭荃完成签到 ,获得积分0
1分钟前
jianguo完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Wearable Exoskeleton Systems, 2nd Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6058263
求助须知:如何正确求助?哪些是违规求助? 7890954
关于积分的说明 16296664
捐赠科研通 5203251
什么是DOI,文献DOI怎么找? 2783828
邀请新用户注册赠送积分活动 1766484
关于科研通互助平台的介绍 1647087